Sfoglia per Rivista  CANCER RESEARCH

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 78
Titolo Data di pubblicazione Autore(i) File
A Secreted Form of ADAM9 by Hepatic Stellate Cells Induces Tumor Invasion Through Stromal-tumor Interactions 2005 A. MAZZOCCA; R. COPPARI; R. DE FRANCO; J-Y. OEL CHO; T. LIBERMANN; M. PINZANI, A. TOKER
Abstract 2471: Pan-cancer catalog of Differentially Methylated Regions by Rocker-meth, a new computational method 2019 Benelli, Matteo; Magi, Alberto; Romagnoli, Dario; Franceschini, Gian Marco; Biagioni, Chiara; Migliaccio, Ilenia; Malorni, Luca; Leo, Angelo Di; Demichelis, Francesca
Abstract P6-02-07: Metabolomic analysis by nuclear magnetic resonance spectroscopy discriminates hormone receptor positive/HER2 negative breast cancer cell lines resistant to palbociclib 2017 Bonechi, M; Guarducci, C; Meoni, G; Tenori, L; Biagioni, C; Schiff, R; Osborne, Ck; Luchinat, C; Di Leo, A; Malorni, L; Migliaccio, I
Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. 1991 A. E. Bale; J. A. Norton; E. L. Wong; J. S. Fryburg; P. N. Maton; E. H. Oldfield; E. Streeten; G. D. Aurbach; M. L. Brandi; E. Friedman
Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. 2002 ML. TADDEI ; P. CHIARUGI ; P. CIRRI; F. BURICCHI ; T. FIASCHI ; E. GIANNONI ; D. TALINI ; G. COZZI ; L. FORMIGLI ; G. RAUGEI ; G. RAMPONI
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway 1999 L. Mirabelli-Primdahl; R. Gryfe; H. Kim; A. Millar; C. Luceri; D. Dale; E. Holowaty; B. Bapat; S. Gallinger; M. Redston
Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues 2001 Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Brechot P; Brechot C; Kremsdorf D
BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. 2003 OTTINI L.; MASALA G.; D'AMICO C.; MANCINI B.; SAIEVA C.; ACETO G.; GESTRI D.; VEZZOSI V.; FALCHETTI M.; DE MARCO M.; PAGLIERANI M.; CAMA A.; S. BIANCHI; MARIANI-COSTANTINI R.; PALLI D
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines 2009 Mazzanti, R; Solazzo, M; Fantappie, O; D'Amico, M; Sassoli, C; Tani, A; Cipriani, G; Bogani, C; Pestrin, M; Formigli, L
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 2003 A.GOZZINI; E.ROVIDA; P.DELLO SBARBA; S.GALIMBERTI; V. SANTINI
Changes in CuZn-superoxide dismutase during induced differentiation of murine erythroleukemia cells 1988 F. PAOLETTI; MOCALI A.
Common breast cancer susceptibility loci are associated with triple-negative breast cancer 2011 Stevens K.N.; Vachon C.M.; Lee A.M.; Slager S.; Lesnick T.; Olswold C.; Fasching P.A.; Miron P.; Eccles D.; Carpenter J.E.; Godwin A.K.; Ambrosone C.; Winqvist R.; Brauch H.; Schmidt M.K.; Cox A.; Cross S.S.; Sawyer E.; Hartmann A.; Beckmann M.W.; Schulz-Wendtland R.; Ekici A.B.; Tapper W.J.; Gerty S.M.; Durcan L.; Graham N.; Hein R.; Nickels S.; Flesch-Janys D.; Heinz J.; Sinn H.-P.; Konstantopoulou I.; Fostira F.; Pectasides D.; Dimopoulos A.M.; Fountzilas G.; Clarke C.L.; Balleine R.; Olson J.E.; Fredericksen Z.; Diasio R.B.; Pathak H.; Ross E.; Weaver J.; Rudiger T.; Forsti A.; Dunnebier T.; Ademuyiwa F.; Kulkarni S.; Pylkas K.; Jukkola-Vuorinen A.; Ko Y.-D.; Van Limbergen E.; Janssen H.; Peto J.; Fletcher O.; Giles G.G.; Baglietto L.; Verhoef S.; Tomlinson I.; Kosma V.-M.; Beesley J.; Greco D.; Blomqvist C.; Irwanto A.; Liu J.; Blows F.M.; Dawson S.-J.; Margolin S.; Mannermaa A.; Martin N.G.; Montgomery G.W.; Lambrechts D.; Dos Santos Silva I.; Severi G.; Hamann U.; Pharoah P.; Easton D.F.; Chang-Claude J.; Yannoukakos D.; Nevanlinna H.; Wang X.; Couch F.J.
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. 2007 NK.Saxena; D.Sharma; X.Ding; S.Lin; F.Marra; D.Merlin; FA.Anania
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma 2007 GRAMANTIERI, LAURA; FERRACIN, MANUELA; FORNARI, FRANCESCA; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; GRAZI, GIAN LUCA; Croce CM; BOLONDI, LUIGI; Negrini M.
CYTOTOXIC EFFECTS OF FOLATE ANTAGONISTS AGAINST METHOTREXATE-RESISTANT HUMAN LEUKEMIC LYMPHOBLAST CCRF-CEM CELL LINES. 1985 E. MINI; MOROSON B.A.; FRANCO C.T.; BERTINO J.R.
Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells. 2008 Calvani M; Trisciuoglio D; Bergamaschi C; Shoemaker RH; Melillo G.
DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer 2021 Lulli Matteo, Gragnani Laura, Mello Tommaso, Galli Andrea, Carloni Vinicio
Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death 2007 j. LLUIS; F. BURICCHI ; P. CHIARUGI; A. MORALES; J. FERNANDEZ-CHECA
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. 2005 Kong D; Park EJ; Stephen AG; Calvani M; Cardellina JH; Monks A; Fisher RJ; Shoemaker RH; Melillo G.
Effect of dietary carbohydrates on the growth of dysplastic crypt foci in the colon of rats treated with 1,2-dimethylhydrazine. 1991 G. Caderni; F. Bianchini; A. Mancina; M. T. Spagnesi; P. Dolara
Mostrati risultati da 1 a 20 di 78
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile